Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate
- 270 Downloads
For at least three decades, many investigators have reported on the US black/white breast cancer case ratio for estrogen receptor (ER) status as if it reflected an intrinsic biological difference. In light of racial/ethnic differences in declines in the incidence of ER+ breast cancer, as linked to changing use of hormone therapy, we empirically tested whether the black/white breast cancer estrogen receptor ratio has changed over time.
We examined temporal trends in the odds of being ER+ among white as compared to black women among all cases of invasive breast cancer occurring among women residing in the catchment area of the SEER 13 Registries Database between 1992 and 2005.
During the study period, the odds of being ER+ among the white compared to black cases increased from 1992 to 2002 (a statistically significant joinpoint; p < 0.05; peak odds ratio (2002) = 2.25 (95% confidence interval 2.13, 2.39)). Thereafter, the odds ratio leveled off (post-2002 slope not significantly different from zero; p = 0.326). Among women aged 45–54, moreover, the post-2002 decline tended toward statistical significance (p = 0.0891).
The results suggest the black/white breast cancer case estrogen receptor ratio is historically contingent, not innate.
KeywordsBlack Breast cancer Cancer disparities Estrogen receptor Social determinants of health White
This project was funded by the National Institutes of Health (grant 5R03CA132131 to NK).
- 5.Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results Database. Cancer 110:876–884CrossRefPubMedGoogle Scholar
- 6.Banks E, Canfell K (2010) Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Res 12:103. http://breast-cancer-research.com/12/1/103
- 12.Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973–2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission. http://seer.cancer.gov/data/index.html. Accessed 3 August 2009
- 13.Anderson RN, Rosenberg HM (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 37(3)Google Scholar
- 16.Kunitz S (2006) The health of populations: general theories and particular realities. Oxford University Press, OxfordGoogle Scholar
- 19.Brandt A (2007) The cigarette century: the rise, fall, and deadly persistence of the product that defined America. Basic Books, New YorkGoogle Scholar
- 20.National Center for Health Statistics (2009) Health, United States 2009. Table 36: death rates for malignant neoplasm of breast among females, by race, Hispanic origin, and age: United States, selected years 1950–2006. National Center for Health Statistics, Hyattsville, p 224Google Scholar
- 21.Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2010) SEER cancer statistics review, 1975–2006. National Cancer Institute, Bethesda. Available at: http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009; see: Table 4.6. Cancer of the breast (Invasive). Age-adjusted US death rates by year, race, and sex. Available at: http://seer.cancer.gov/csr/1975_2006/results_merged/sect_04_breast.pdf. Accessed 3 June 2010
- 24.Krieger N (ed) (2004) Embodying inequality: epidemiologic perspectives. Baywood Publishing Co, AmityvilleGoogle Scholar